Neumega
Used for Chronic ITP
Used for Chronic ITP
Neumega (oprelvekin) is a medication used to prevent severely low platelet levels in adults receving a certain type of chemotherapy (anti-cancer medication). It's no longer available in the United States, because it was discontinued.
What is Neumega (oprelvekin)?
Drug facts
| Common Brands | Neumega |
|---|---|
| Drug Class | Platelet growth factor |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Discontinued |
Neumega (oprelvekin) dosage
Typical dosage for Neumega (oprelvekin)
Interactions between Neumega (oprelvekin) and other drugs
Neumega (oprelvekin) may interact with certain medications or supplements. Always let your doctor and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking. The list below does not include all possible drug interactions with Neumega (oprelvekin). Please note that only the generic name of each medication is listed below.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
